Krzysztof Mrózek spends much of his time researching Leukemia, Myeloid leukemia, Internal medicine, Oncology and Immunology. His biological study spans a wide range of topics, including Cancer, Fms-Like Tyrosine Kinase 3, Myeloid, CEBPA and NPM1. Krzysztof Mrózek combines subjects such as Hematology and Gene expression profiling with his study of NPM1. His studies deal with areas such as Gastroenterology, Adult Acute Myeloid Leukemia and BAALC, Cytogenetics as well as Myeloid leukemia. His work on Survival analysis, Survival rate, Cytarabine and Group B as part of general Internal medicine study is frequently linked to FLT3 Internal Tandem Duplication, therefore connecting diverse disciplines of science. In his research on the topic of Oncology, MLL Partial Tandem Duplication is strongly related with Pathology.